HK1130052A1 - Antitumoral dihydropyran-2-one compounds - Google Patents

Antitumoral dihydropyran-2-one compounds

Info

Publication number: HK1130052A1
Authority: HK; Hong Kong
Prior art keywords: compounds; antitumoral; dihydropyran; antitumoral dihydropyran
Prior art date: 2006-06-16

Application number

HK09108044.0A

Other languages

English (en)

Inventor

Lopez Ma Jesus Martin

Molinero Laura Coello

Benitez Jose Fernando Reyes

Vicente Alberto Rodriguez

Garcia-Ibarrola Maria Garranzo

Perez Carmen Murcia

Solloso Andres Francesch

Sancho Francisco Sanchez

Marchante Maria Del Carmen Cuevas

Rodriguez Rogelio Fernandez

Original Assignee

Pharma Mar Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-16

Filing date

2009-09-03

Publication date

2009-12-18

2009-09-03 Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa

2009-12-18 Publication of HK1130052A1 publication Critical patent/HK1130052A1/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pyrane Compounds (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

HK09108044.0A 2006-06-16 2009-09-03 Antitumoral dihydropyran-2-one compounds HK1130052A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06380173		2006-06-16
PCT/EP2007/055959 WO2007144423A1 (en)	2006-06-16	2007-06-15	Antitumoral dihydropyran-2-one compounds

Publications (1)

Publication Number	Publication Date
HK1130052A1 true HK1130052A1 (en)	2009-12-18

Family

ID=38508885

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK09108044.0A HK1130052A1 (en)	2006-06-16	2009-09-03	Antitumoral dihydropyran-2-one compounds

Country Status (30)

Country	Link
US (2)	US8324406B2 (xx)
EP (3)	EP2404912A3 (xx)
JP (2)	JP5117491B2 (xx)
KR (1)	KR101474031B1 (xx)
CN (2)	CN101679340B (xx)
AR (1)	AR061506A1 (xx)
AT (1)	ATE522514T1 (xx)
AU (1)	AU2007259257B8 (xx)
BR (2)	BRPI0722429A2 (xx)
CA (1)	CA2654334C (xx)
CY (1)	CY1112103T1 (xx)
DK (1)	DK2032551T3 (xx)
ES (1)	ES2371942T3 (xx)
HK (1)	HK1130052A1 (xx)
HR (1)	HRP20110845T1 (xx)
IL (1)	IL195676A (xx)
MX (1)	MX2008015754A (xx)
MY (1)	MY145788A (xx)
NO (2)	NO341508B1 (xx)
NZ (1)	NZ573706A (xx)
PL (1)	PL2032551T3 (xx)
PT (1)	PT2032551E (xx)
RS (1)	RS52034B (xx)
RU (2)	RU2444519C2 (xx)
SG (1)	SG174830A1 (xx)
SI (1)	SI2032551T1 (xx)
TW (2)	TWI373469B (xx)
UA (1)	UA97369C2 (xx)
WO (1)	WO2007144423A1 (xx)
ZA (1)	ZA200810315B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2384420T3 (es)	2007-12-20	2012-07-04	Pharma Mar S.A.	Compuestos antitumorales
WO2009104147A2 (en)	2008-02-20	2009-08-27	Actelion Pharmaceuticals Ltd	Azatricyclic antibiotic compounds
US8349826B2 (en)	2008-02-22	2013-01-08	Actelion Pharmaceuticals Ltd.	Oxazolidinone derivatives
PT2344495E (pt)	2008-10-07	2015-04-01	Actelion Pharmaceuticals Ltd	Compostos antibióticos de oxazolidinona tricíclica
BRPI0920870A2 (pt)	2008-10-10	2018-06-26	Actelion Pharmaceuticals Ltd	antibióticos de oxazolidinila.
WO2010149688A2 (en)	2009-06-24	2010-12-29	Pharma Mar, S.A.	Antitumoral compounds
GB201309807D0 (en) *	2013-05-31	2013-07-17	Pharma Mar Sau	Antibody drug conjugates
CN108467378A (zh) *	2017-02-23	2018-08-31	复旦大学	一种二氢吡喃酮类化合物及其制备方法和用途
JOP20190254A1 (ar)	2017-04-27	2019-10-27	Pharma Mar Sa	مركبات مضادة للأورام
CN110790737B (zh) *	2019-11-07	2022-07-22	河南中烟工业有限责任公司	一种2,3-二氢-3,5-二羟基-6-乙基-4h-吡喃-4-酮的制备方法
AU2022369058A1 (en)	2021-10-22	2024-05-02	Pharma Mar, S.A.	Antitumoral compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA938019B (en) *	1992-11-13	1995-04-28	Upjohn Co	Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
ATE263761T1 (de) *	1993-11-19	2004-04-15	Parke Davis & Co	5,6-dihydropyronderivate als proteaseinhibitoren und antiviralmittel
US7446196B2 (en) *	2004-06-03	2008-11-04	Kosan Biosciences, Incorporated	Leptomycin compounds

2007
- 2007-06-15 AU AU2007259257A patent/AU2007259257B8/en active Active
- 2007-06-15 RS RS20110495A patent/RS52034B/en unknown
- 2007-06-15 BR BRPI0722429-0A patent/BRPI0722429A2/pt not_active IP Right Cessation
- 2007-06-15 PT PT07765445T patent/PT2032551E/pt unknown
- 2007-06-15 EP EP11177474A patent/EP2404912A3/en not_active Withdrawn
- 2007-06-15 SI SI200730781T patent/SI2032551T1/sl unknown
- 2007-06-15 JP JP2009514811A patent/JP5117491B2/ja active Active
- 2007-06-15 NZ NZ573706A patent/NZ573706A/en unknown
- 2007-06-15 SG SG2011067998A patent/SG174830A1/en unknown
- 2007-06-15 DK DK07765445.7T patent/DK2032551T3/da active
- 2007-06-15 US US12/304,123 patent/US8324406B2/en active Active
- 2007-06-15 CA CA2654334A patent/CA2654334C/en active Active
- 2007-06-15 MX MX2008015754A patent/MX2008015754A/es active IP Right Grant
- 2007-06-15 CN CN2007800222645A patent/CN101679340B/zh active Active
- 2007-06-15 AT AT07765445T patent/ATE522514T1/de active
- 2007-06-15 UA UAA200900292A patent/UA97369C2/ru unknown
- 2007-06-15 ES ES07765445T patent/ES2371942T3/es active Active
- 2007-06-15 PL PL07765445T patent/PL2032551T3/pl unknown
- 2007-06-15 MY MYPI20085040A patent/MY145788A/en unknown
- 2007-06-15 CN CN2011102036625A patent/CN102336730A/zh active Pending
- 2007-06-15 EP EP07765445A patent/EP2032551B9/en active Active
- 2007-06-15 WO PCT/EP2007/055959 patent/WO2007144423A1/en active Application Filing
- 2007-06-15 EP EP11177479A patent/EP2404913A3/en not_active Withdrawn
- 2007-06-15 BR BRPI0713031A patent/BRPI0713031B8/pt active IP Right Grant
- 2007-06-15 RU RU2009101150/04A patent/RU2444519C2/ru active
- 2007-06-15 KR KR1020097000830A patent/KR101474031B1/ko active IP Right Grant
- 2007-06-19 AR ARP070102670A patent/AR061506A1/es active IP Right Grant
- 2007-06-20 TW TW096122071A patent/TWI373469B/zh active
- 2007-06-20 TW TW100146802A patent/TW201213316A/zh unknown
2008
- 2008-12-02 IL IL195676A patent/IL195676A/en active IP Right Grant
- 2008-12-04 ZA ZA2008/10315A patent/ZA200810315B/en unknown
2009
- 2009-01-06 NO NO20090054A patent/NO341508B1/no unknown
- 2009-09-03 HK HK09108044.0A patent/HK1130052A1/xx unknown
2011
- 2011-06-29 US US13/171,567 patent/US8501968B2/en active Active
- 2011-08-05 RU RU2011133128/04A patent/RU2011133128A/ru not_active Application Discontinuation
- 2011-09-14 NO NO20111248A patent/NO20111248L/no not_active Application Discontinuation
- 2011-10-05 JP JP2011220925A patent/JP2012021023A/ja active Pending
- 2011-11-14 HR HR20110845T patent/HRP20110845T1/hr unknown
- 2011-11-30 CY CY20111101175T patent/CY1112103T1/el unknown

Also Published As

Publication number	Publication date
EP2032551A1 (en)	2009-03-11
ATE522514T1 (de)	2011-09-15
HRP20110845T1 (hr)	2011-12-31
ZA200810315B (en)	2010-02-24
RS52034B (en)	2012-04-30
BRPI0713031B1 (pt)	2020-10-06
IL195676A0 (en)	2009-09-01
CA2654334C (en)	2014-06-10
MY145788A (en)	2012-04-30
NO20090054L (no)	2009-01-06
NZ573706A (en)	2011-09-30
CA2654334A1 (en)	2007-12-21
UA97369C2 (ru)	2012-02-10
EP2032551B1 (en)	2011-08-31
JP2012021023A (ja)	2012-02-02
CN101679340A (zh)	2010-03-24
US20100048690A2 (en)	2010-02-25
IL195676A (en)	2012-06-28
EP2404913A3 (en)	2012-06-06
CN101679340B (zh)	2013-06-05
AU2007259257A1 (en)	2007-12-21
MX2008015754A (es)	2009-01-12
BRPI0713031B8 (pt)	2021-05-25
RU2444519C2 (ru)	2012-03-10
US20120190870A1 (en)	2012-07-26
EP2032551B9 (en)	2012-02-29
BRPI0722429A2 (pt)	2013-11-26
AU2007259257B2 (en)	2011-12-08
AU2007259257A8 (en)	2012-04-05
US8501968B2 (en)	2013-08-06
RU2009101150A (ru)	2010-07-27
BRPI0713031A2 (pt)	2013-03-12
KR101474031B1 (ko)	2014-12-17
RU2011133128A (ru)	2013-02-10
ES2371942T3 (es)	2012-01-11
NO341508B1 (no)	2017-11-27
KR20090024261A (ko)	2009-03-06
TW201213316A (en)	2012-04-01
CY1112103T1 (el)	2015-11-04
SI2032551T1 (sl)	2012-01-31
TW200811128A (en)	2008-03-01
PL2032551T3 (pl)	2012-01-31
AR061506A1 (es)	2008-09-03
DK2032551T3 (da)	2012-01-02
EP2404912A2 (en)	2012-01-11
PT2032551E (pt)	2011-12-06
AU2007259257B8 (en)	2012-04-05
CN102336730A (zh)	2012-02-01
US20090186938A1 (en)	2009-07-23
JP2009539943A (ja)	2009-11-19
US8324406B2 (en)	2012-12-04
NO20111248L (no)	2008-12-16
JP5117491B2 (ja)	2013-01-16
SG174830A1 (en)	2011-10-28
WO2007144423A1 (en)	2007-12-21
EP2404912A3 (en)	2012-07-25
EP2404913A2 (en)	2012-01-11
TWI373469B (en)	2012-10-01

Publication	Publication Date	Title
GB0602424D0 (en)	2006-03-22	Compounds
GB0602046D0 (en)	2006-03-15	Compounds
IL195676A0 (en)	2009-09-01	Antitumoral dihydropyran-2-one compounds
EP1984379A4 (en)	2011-05-18	ANTI-ARENAVIRAL COMPOUNDS
EP2082022A4 (en)	2011-12-07	COMPOUNDS
HK1149022A1 (en)	2011-09-23	Antitumoral compounds
EP2004174A4 (en)	2010-07-28	NAPHTHALENEDIONED COMPOUNDS
GB0602042D0 (en)	2006-03-15	Compounds
ZA200800615B (en)	2009-01-28	Antitumoral compounds
EP1973905A4 (en)	2010-12-08	COMPOUNDS
GB0523098D0 (en)	2005-12-21	Antitumoral compounds
AP2009004767A0 (en)	2009-02-28	Cubstituted azolin-2-yl-amino compounds
EP2016069A4 (en)	2011-01-26	BISPYRIDINIUMVERBINDUNGEN
GB0602560D0 (en)	2006-03-22	Compounds
GB0602412D0 (en)	2006-03-15	Compounds
GB0600427D0 (en)	2006-02-15	Compounds
GB0622870D0 (en)	2006-12-27	Antitumoral compounds
GB0623952D0 (en)	2007-01-10	Antitumoral compounds
GB0605081D0 (en)	2006-04-26	Antitumoral compounds
GB0722495D0 (en)	2007-12-27	Antitumoral compounds
GB0723376D0 (en)	2008-01-09	Antitumoral compounds
GB0704990D0 (en)	2007-04-25	Antitumoral compounds
GB0520279D0 (en)	2005-11-16	Antitumoral compounds
GB0520292D0 (en)	2005-11-16	Antitumoral compounds
GB0523164D0 (en)	2005-12-21	Antitumoral compounds